Overview of Paediatric HSCT Website

 

Overview of Paediatric HSCT - The Past, The Present and Future Directions

Pre VIVA-Asia Nursing Symposium Session

7 Dec 2025, Sat | 9:00AM - 10:00AM (GMT+8 SG Time)*

Check your Time Zone 

Join us for the Pre VIVA-Asia Nursing Symposium Session on December 7, 2024 (Saturday) from 9:00 AM - 10:00 AM (GMT+8, Singapore Time). Ms. Pham Thi Ngoc Anh from KK Women's and Children's Hospital will lead this insightful session, focusing on the history, current advancements, and future directions in Paediatric Hematopoietic Stem Cell Transplantation (HSCT).

 

 

PROGRAMME RUNDOWN


 Overview of Paediatric HSCT Programme

 

PRESENTATION SUMMARIES


Overview of Paediatric HSCT - The Past, The Present and Future Directions by Ms Pham Thi Ngoc Anh

Over the past 2 decades, paediatric HSCT has improved significantly, with decreased mortality rate (< 10%), and increased survival rates (> 80%). Indications for HSCT has expanded beyond malignant conditions to include inherited metabolic disorders, sickle cell disease, thalassemia, and autoimmune disorders. 

Alongside HSCT advancement, nurses continue to play an essential role in ensuring best holistic care is delivered.  The future holds promise with personalised treatment, cellular therapy advancement, gene editing, and less toxicity conditioning regimens. While challenges remain, opportunities lie in global collaboration, education, training, and research advancing.  

 

SPEAKERS


 

Prof Liem

Ms Pham Thi Ngoc Anh 

Advanced Practice Nurse
Department Paediatric Haematology Oncology
KK Women’s and Children’s Hospital
Singapore

 

  

  

MODERATOR


 

Ms Laura Tan

Ms Laura Mei Lian Tan

Senior Nursing Lecturer, Global Outreach Program (Asia Pacific Region)
Paediatric Oncology, Department of Paediatrics
VIVA-University Children's Cancer Centre, National University Hospital
Singapore